New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Following the lead of other states, New York racing officials have formed an advisory panel to bolster efforts to track new developments in legal and illegal drugs used in the thoroughbred industry. "There's no agenda going into this,'' said Racing and Wagering Board chairman Michael Hoblock, who announced the creation of the Medication Advisory Committee Thursday. He said the idea of such a panel came out of meetings over the past several years the racing board has held with the New York Racing Association's organization of horsemen.
Most Popular Stories
- After the Wire: Rebel Stakes
- Gulfstream Race is 'No Contest' After Spill
- Rebel Rematch Expected in Arkansas Derby
- California Chrome 'Wait and See' for SA Derby
- Stormy Lucy Ends Graded Drought in Santa Ana
- Hoppertunity Stays Up in Roughshod Rebel
- Featured Horse Profile: Close Hatches
- Likely Entrants for World Cup Card Released
- Onlyforyou Euthanized After Training Accident
- KY-Bred Lideris Wins Latinoamericana in Peru